The Latest in Precision Medicine and Lung Cancer

Even before President Barack Obama declared it a national initiative, precision medicine has helped bring more effective treatment to patients with many types of cancer. One disease that has benefited from these treatments is lung cancer, where targeted therapies have significantly improved outcomes for patients.

(From L-R) David Jackman, MD, Barrett Rollins, MD, PhD, and moderator Anne Doerr.

(From L-R) David Jackman, MD, Barrett Rollins, MD, PhD, and moderator Anne Doerr.

“When we find we have drugs targeted for a specific genetic mutation driving the cancer, the chance of having someone live longer and feel better is much higher,” says David Jackman, MD, a medical oncologist with Dana-Farber’s Lowe Center for Thoracic Oncology and the institute’s Medical Director for Clinical Pathways. “We’re doubling, tripling, and in some cases quadrupling response rates compared to what we see with traditional chemotherapy.”

Jackman recently joined Dana-Farber Chief Scientific Officer Barrett Rollins, MD, PhD, for a live video webchat on the latest in precision medicine for lung cancer. Jackman and Rollins discussed how precision medicine is being used in cancer treatment today as well as some of the latest research in the field.

“One of the more exciting areas in precision medicine is looking at why patients sometimes develop resistance to these treatments,” says Rollins. “The next cutting-edge area of cancer research is going to focus on how we can overcome this problem.”

Learn more by watching the webchat recording below:

See more from our live cancer webchat series.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.